Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 3,510 NXTC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | NextCure, Inc. (NXTC) | Grant/Award | 3,510 | n/a |
| Jun 24, 2025 | NextCure, Inc. (NXTC) | Grant/Award | 28,050 | n/a |
| Jun 21, 2024 | NextCure, Inc. (NXTC) | Grant/Award | 28,050 | n/a |
| Jun 23, 2023 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |
| Jun 24, 2022 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |
| Jun 28, 2021 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |
| Jun 21, 2021 | CASTLE BIOSCIENCES INC (CSTL) | Sale | 30,000 | $2.25M |
| Jun 14, 2021 | CASTLE BIOSCIENCES INC (CSTL) | Grant/Award | 3,379 | n/a |
| Apr 7, 2021 | CASTLE BIOSCIENCES INC (CSTL) | Sale | 50,000 | $3.59M |
| Apr 2, 2021 | CASTLE BIOSCIENCES INC (CSTL) | Sale | 20,000 | $1.35M |